MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
{{output}}
Introduction: Early identification of chemoresistance in patients with ovarian cancer is of utmost importance in order to provide them with the most appropriate therapy. Recently, we described the expression of MyD88 in ovarian c... ...